Posted On: 08/15/2016 3:49:54 PM
Post# of 94287

$ARTH .64 over 3.4 million in volume! Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
http://finance.yahoo.com/news/arch-therapeuti...00951.html
http://finance.yahoo.com/news/arch-therapeuti...00951.html

